Dave Evans
Consultant Software Developer
Dave began working with the Bennett Institute in 2018 — initially on the OpenPrescribing project and later, in the early days of the pandemic, on the first version of what would become the OpenSAFELY platform. Over the last two decades he has worked with organisations of all shapes and sizes (from startups to multinationals) to solve problems with software and data.
He once laboured under the illusion that he wanted to be a philosopher and has a BA and an MPhil in the subject.
Papers by Dave Evans
- Impact of COVID-19 on recorded blood pressure screening and hypertension management in England
- Consistency, completeness and external validity of ethnicity recording in NHS primary care records: a cohort study in 25 million patients’ records at source using OpenSAFELY
- Data-Driven Identification of Potentially Successful Intervention Implementations Using 5 Years of Opioid Prescribing Data
- Incidence and treatment of group A streptococcal infections during covid-19 pandemic and 2022 outbreak
- The impact of the COVID-19 pandemic on Antidepressant Prescribing with a focus on people with learning disability and autism
- The impact of COVID-19 on medication reviews in English primary care
- Measuring BMI in 22 million patients in England
- OpenSAFELY: a platform for analysing electronic health records designed for reproducible research
- Trends in inequalities in avoidable hospitalisations across the COVID-19 pandemic
- Interpreting pathology test result values with comparators (<, >) in Electronic Health Records research
- Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home
- Eleven key measures for monitoring general practice clinical activity during COVID-19
- Changes in medication safety indicators in England throughout the covid-19 pandemic using OpenSAFELY
- Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational Data
- Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022
- Data-Driven Identification of Unusual Prescribing Behavior: Analysis and Use of an Interactive Data Tool Using 6 Months of Primary Care Data From 6500 Practices in England
- Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings
- OpenSAFELY NHS Service Restoration Observatory 2
- Identifying Patterns of Clinical Interest in Clinicians' Treatment Preferences: Hypothesis-free Data Science Approach to Prioritizing Prescribing Outliers for Clinical Review
- Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community
- Recording of ‘COVID-19 vaccine declined’
- Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose
- Comparative effectiveness of ChAdOx1 versus BNT162b2 COVID-19 vaccines in Health and Social Care workers in England
- Representativeness of electronic health record platform OpenSAFELY-TPP data compared to the population of England
- Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England
- Association between oral anticoagulants and COVID-19-related outcomes
- Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies
- Safety of COVID-19 vaccination and acute neurological events
- Accident and emergency (AE) attendance in England following infection with SARS-CoV-2 Omicron or Delta
- Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19 in England
- Comparison of methods for predicting COVID-19-related death in the general population using the OpenSAFELY platform
- Potentially inappropriate prescribing of DOACs to people with mechanical heart valves
- Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation
- Mortality among Care Home Residents in England during the first and second waves of the COVID-19 pandemic
- OpenSAFELY NHS Service Restoration Observatory 1: primary care clinical activity in England during the first wave of COVID-19
- Trends and clinical characteristics of COVID-19 vaccine recipients
- Impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic
- Clinical coding of long COVID in English primary care
- Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants
- Severity of Severe Acute Respiratory System Coronavirus 2 (SARS-CoV-2) Alpha Variant (B.1.1.7) in England
- Risks of covid-19 hospital admission and death for people with learning disability
- Factors associated with deaths due to COVID-19 versus other causes
- Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England
- Identifying Care Home Residents in Electronic Health Records
- Association between living with children and outcomes from covid-19
- Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7
- Changes in the rate of cardiometabolic and pulmonary events during the COVID-19 pandemic
- Short report: Ethnicity and COVID-19 death in the early part of the COVID-19 second wave in England
- Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19
- HIV infection and COVID-19 death
- Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality
- Comparison of different risk prediction modelling approaches for COVID-19 related death using the OpenSAFELY platform
- Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids
- Factors associated with COVID-19-related death using OpenSAFELY